Targeting interleukin-21 in immune-mediated pathologies.

Targeting interleukin-21 in immune-mediated pathologies.

Item
http://www.wikidata.org/entity/Q37656362
Increased IL-21 secretion by aged CD4+T cells is associated with prolonged STAT-4 activation and CMV seropositivity.Effect of malnutrition on the expression of cytokines involved in Th1 cell differentiationT Cells in Celiac Disease.Alterations of circulating follicular helper T cells and interleukin 21 in diffuse large B-cell lymphoma.Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.The PTPN22 1858T allele but not variants in the proximal promoter region of IL-21 gene is associated with the susceptibility to type 1 diabetes and the presence of autoantibodies in a Brazilian cohortIgM response against amyloid-beta in aging: a potential peripheral protective mechanism
P2860

Targeting interleukin-21 in immune-mediated pathologies.

Item
http://www.wikidata.org/entity/Q37656362
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting interleukin-21 in immune-mediated pathologies.
@en
Targeting interleukin-21 in immune-mediated pathologies.
@nl
type
label
Targeting interleukin-21 in immune-mediated pathologies.
@en
Targeting interleukin-21 in immune-mediated pathologies.
@nl
prefLabel
Targeting interleukin-21 in immune-mediated pathologies.
@en
Targeting interleukin-21 in immune-mediated pathologies.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Targeting interleukin-21 in immune-mediated pathologies.
@en
P2093
P304
P31
P356
10.2174/138945010791011910
P433
P478
P577
P698
P921